Evidence map›Paper›PMID 25609815›Full record

ArticleJournal of virology2015

A trans-dominant form of Gag restricts Ty1 retrotransposition and mediates copy number control.

Agniva Saha, Jessica A Mitchell, Yuri Nishida, Jonathan E Hildreth, Joshua A Ariberre, Wendy V Gilbert, David J Garfinkel

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Capsid flexibility during Ty1 virus-like particle assembly.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. An interchangeable prion-like domain is required for Ty1 retrotransposition.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Transposon control as a checkpoint for tissue regeneration.Development (Cambridge, England) · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Agniva SahaDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
Jessica A MitchellDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
Yuri NishidaDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
Jonathan E HildrethDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
Joshua A AriberreDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Wendy V GilbertDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
David J GarfinkelDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA djgarf@bmb.uga.edu.
University of Georgia · USMassachusetts Institute of Technology · US

Funding

Ribosome Specialization and RegulationR01GM094303 · NIGMS · YALE UNIVERSITY · PI GILBERT, WENDY VICTORIA · 2012 to 2016
$1.5M
Antisense RNAs control retrotransposon copy numberR01GM095622 · NIGMS · UNIVERSITY OF GEORGIA · PI GARFINKEL, DAVID J. · 2011 to 2014
$1.1M
Mechanisms and Regulation of Yeast Internal Ribosome Entry SitesR00GM081399 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GILBERT, WENDY VICTORIA · 2008 to 2010
$915k
Investigating the Ago Cleavage Independent Mechanism(s) of RNAiF32GM112474 · NIGMS · STANFORD UNIVERSITY · PI ARRIBERE, JOSHUA · 2014 to 2017
$141k
Mechanisms and Regulation of Yeast Internal Ribosome Entry SitesK99GM081399 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI GILBERT, WENDY VICTORIA · 2007 to 2007
$90k
NIGMS NIH HHS 1F32GM112474-01NIGMS NIH HHS F32 GM112474NIGMS NIH HHS GM095622NIGMS NIH HHS K99 GM081399NIGMS NIH HHS R00 GM081399NIGMS NIH HHS R01 GM094303NIGMS NIH HHS R01 GM095622
6 · The paper itself

Abstract

unlabelledSaccharomyces cerevisiae and Saccharomyces paradoxus lack the conserved RNA interference pathway and utilize a novel form of copy number control (CNC) to inhibit Ty1 retrotransposition. Although noncoding transcripts have been implicated in CNC, here we present evidence that a truncated form of the Gag capsid protein (p22) or its processed form (p18) is necessary and sufficient for CNC and likely encoded by Ty1 internal transcripts. Coexpression of p22/p18 and Ty1 decreases mobility more than 30,000-fold. p22/p18 cofractionates with Ty1 virus-like particles (VLPs) and affects VLP yield, protein composition, and morphology. Although p22/p18 and Gag colocalize in the cytoplasm, p22/p18 disrupts sites used for VLP assembly. Glutathione S-transferase (GST) affinity pulldowns also suggest that p18 and Gag interact. Therefore, this intrinsic Gag-like restriction factor confers CNC by interfering with VLP assembly and function and expands the strategies used to limit retroelement propagation. IMPORTANCE: Retrotransposons dominate the chromosomal landscape in many eukaryotes, can cause mutations by insertion or genome rearrangement, and are evolutionarily related to retroviruses such as HIV. Thus, understanding factors that limit transposition and retroviral replication is fundamentally important. The present work describes a retrotransposon-encoded restriction protein derived from the capsid gene of the yeast Ty1 element that disrupts virus-like particle assembly in a dose-dependent manner. This form of copy number control acts as a molecular rheostat, allowing high levels of retrotransposition when few Ty1 elements are present and inhibiting transposition as copy number increases. Thus, yeast and Ty1 have coevolved a form of copy number control that is beneficial to both "host and parasite." To our knowledge, this is the first Gag-like retrotransposon restriction factor described in the literature and expands the ways in which restriction proteins modulate retroelement replication.

Indexed as

Recombination, GeneticRetroelementsgag Gene Products, Human Immunodeficiency VirusGene ExpressionProtein Interaction MappingRecombinant ProteinsSaccharomyces cerevisiaeVirosomesVirus Assemblygag Gene Products, Human Immunodeficiency VirusRecombinant ProteinsRetroelementsVirosomes

Identifiers

PMID25609815
PMCPMC4403431
OpenAlexW2002538481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.